HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Argyrophilic nucleolar organizer regions staining is useful in predicting recurrence-free interval in oral tongue and floor of mouth squamous cell carcinoma.

AbstractBACKGROUND:
Argyrophilic nucleolar organizer regions (AgNORs) represent a tissue marker of cell proliferative activity. The purpose of this study was to assess the prognostic value of AgNORs expression in oral squamous cell carcinoma (SCC).
METHODS:
The AgNORs area/nucleus was studied in paraffin sections by means of digital image analysis in 43 cases of stage II oral tongue and floor of the mouth SCC.
RESULTS:
Time free of disease was considered a dependent variable of a binary indicator of AgNORs expression (7.77 microns2/nucleus as a cut-off point). High AgNORs level was associated with a statistically significant negative effect on recurrence-free interval of disease in a Cox proportional hazards models controlled for occult lymph node metastasis, involvement of the surgical margins, thickness of the lesion, and vascular invasion.
CONCLUSIONS:
The AgNORs area increased the capability of predicting which patients have a high risk of recurrence of cancer, and its evaluation may provide useful information for the therapeutic approach to the oral tongue and floor of the mouth SCC.
AuthorsG Teixeira, L Antonangelo, L Kowalski, P Saldiva, A Ferraz, G Silva Filho
JournalAmerican journal of surgery (Am J Surg) Vol. 172 Issue 6 Pg. 684-8 (Dec 1996) ISSN: 0002-9610 [Print] United States
PMID8988678 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Analysis of Variance
  • Carcinoma, Squamous Cell (pathology, ultrastructure)
  • Female
  • Histocytochemistry
  • Humans
  • Male
  • Middle Aged
  • Mouth Neoplasms (pathology, ultrastructure)
  • Neoplasm Recurrence, Local (pathology, ultrastructure)
  • Nucleolus Organizer Region (ultrastructure)
  • Prognosis
  • Proportional Hazards Models
  • Silver Staining
  • Tongue Neoplasms (pathology, ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: